Web platform using a chatbot to help manage hypertension
PROMBot: a Web Platform for Collecting Patient-Reported Outcome Measures Via a Chatbot
This study tests if a chatbot on a web platform can help people with high blood pressure manage their condition better and stay engaged in their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Value for Health CoLAB Academic / other |
| Locations | 1 site (Lisbon, Lisbon District) |
| Trial ID | NCT06845007 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of the PROMBot service, a web platform designed to assist patients in managing their hypertension through a chatbot interface. The study aims to simplify the follow-up process and empower patients to take an active role in their care. By leveraging remote patient monitoring technologies, the study seeks to improve patient outcomes and enhance the continuity of care. The research will assess how well the chatbot can facilitate patient engagement and improve knowledge about blood pressure management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 75 who have been diagnosed with hypertension and can independently perform daily activities.
Not a fit: Patients with mobility limitations, a diagnosis of Parkinson's disease or cancer, or those without access to a smartphone with internet may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better management of hypertension and improved patient engagement in their own health care.
How similar studies have performed: Previous studies have shown that chatbots can effectively enhance patient engagement and knowledge in managing chronic conditions, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 75 years old. * Diagnosed with hypertension, based on ICD-9 codes (401-401.9). * Independent in performing activities of daily living. * Ability to respond to SMS messages. Exclusion Criteria: * Diagnosis of Parkinson's disease. * Refusal to sign the informed consent form. * Diagnosis of cancer. * Mobility limitations that prevent engaging in physical activity. * Lack of a smartphone with internet access.
Where this trial is running
Lisbon, Lisbon District
- Cuf — Lisbon, Lisbon District, Portugal (Recruiting)
Study contacts
- Study coordinator: Soraia Ferreira, PhD
- Email: soraia.ferreira@vohcolab.org
- Phone: 969307101
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.